Eledon Pharmaceuticals, Inc.
ELDN
$2.62
$0.0451.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.86% | -10.91% | 79.28% | -6.48% | 95.07% |
| Total Receivables | -7.36% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.33% | -68.30% | 121.66% | -16.73% | -31.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -81.82% | -92.46% | 64.93% | 181.53% | 190.74% |
| Total Current Assets | -12.77% | -11.14% | 76.34% | -6.55% | 81.80% |
|
|
|||||
| Total Current Assets | -12.77% | -11.14% | 76.34% | -6.55% | 81.80% |
| Net Property, Plant & Equipment | -9.06% | -8.21% | 96.60% | -24.15% | 130.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.26% | -2.48% | 72.86% | -17.65% | 37.84% |
| Total Assets | -10.17% | -9.07% | 54.84% | -4.90% | 49.08% |
|
|
|||||
| Total Accounts Payable | 101.00% | -50.27% | -0.46% | 172.81% | 15.24% |
| Total Accrued Expenses | 26.73% | 9.74% | -15.72% | 78.58% | 71.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.38% | 3.50% | 68.82% | -30.86% | -5.28% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 49.36% | -20.66% | -7.30% | 107.29% | 41.86% |
|
|
|||||
| Total Current Liabilities | 49.36% | -20.66% | -7.30% | 107.29% | 41.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.86% | -13.28% | 103.17% | -18.39% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.24% | -21.38% | 82.97% | -79.02% | 34.25% |
| Total Liabilities | -16.79% | -21.15% | 53.86% | -70.14% | 35.00% |
|
|
|||||
| Common Stock & APIC | -11.12% | 0.63% | 22.43% | 1.97% | 15.58% |
| Retained Earnings | -3.10% | -1.83% | -14.35% | 19.84% | -13.09% |
| Treasury Stock & Other | -166.67% | -169.23% | -74.51% | -- | -- |
| Total Common Equity | -56.07% | -3.01% | 55.33% | 994.69% | 42.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -56.07% | -3.01% | 55.33% | 994.69% | 42.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.46% | -3.01% | 55.33% | 994.69% | 42.28% |
|
|
|||||